budesonide
UkraineDrugs containing this active substance
-
The drug is used for the prophylactic treatment of bronchial asthma in adults and children. It is also recommended for infants and children with croup (laryngotracheobronchitis) requiring hospitalization.
Form: suspension, for inhalation
Active substance Dosage budesonide 0.25 mg/ml ATC: R03BA02
Manufacturer: Pharmaceutical Plant "Polpharma" S.A. (manufacturing, packaging, batch control and batch release)
-
The drug is used for the prophylactic treatment of bronchial asthma in adults and children. It is also recommended for infants and children with croup (laryngotracheobronchitis) requiring hospitalization.
Form: suspension, for inhalation
Active substance Dosage budesonide 0.5 mg/ml ATC: R03BA02
Manufacturer: Pharmaceutical Plant "Polpharma" S.A. (manufacturing, packaging, batch control and batch release)
-
The drug is used for the treatment of active ulcerative colitis limited to the rectum and sigmoid colon.
Form: foam, rectal
Active substance Dosage budesonide 2 mg per dose ATC: A07EA06
Manufacturer: Dr. Falk Pharma GmbH (Responsible for release of final product batches)
-
The drug is used to treat Crohn's disease (to achieve remission), microscopic colitis, and autoimmune hepatitis.
Form: capsules, hard with enteric-coated granules
Active substance Dosage budesonide 3 mg ATC: A07EA06
Manufacturer: Dr. Falk Pharma GmbH (Responsible for release of final product batches)
-
The drug is used for the treatment of bronchial asthma, exacerbations of chronic obstructive pulmonary disease (COPD), and very severe croup (subglottic laryngitis) in children requiring hospitalization.
Form: suspension, for inhalation
Active substance Dosage budesonide 0.25 mg/ml ATC: R03BA02
Manufacturer: AstraZeneca AB (manufacturing, quality control and batch release)
-
The drug is used for the treatment of bronchial asthma, exacerbations of chronic obstructive pulmonary disease (COPD), and very severe croup (subglottic laryngitis) in children requiring hospitalization.
Form: suspension, for inhalation
Active substance Dosage budesonide 0.5 mg/ml ATC: R03BA02
Manufacturer: AstraZeneca AB (manufacturing, quality control and batch release)
-
The drug is used for the prevention and treatment of persistent bronchial asthma of mild, moderate, and severe courses. It is also effective for the prevention of exercise-induced asthma.
Form: powder for inhalation
Active substance Dosage budesonide 200 mcg ATC: R03BA02
Manufacturer: Orion Corporation
-
The drug is used for the prophylactic treatment of bronchial asthma in adults and children. It is also recommended for infants and children with croup (laryngotracheobronchitis) requiring hospitalization.
Form: suspension, for inhalation
Active substance Dosage budesonide 0.25 mg/ml ATC: R03BA02
Manufacturer: Genetik S.p.A. (manufacturing and packaging, quality control)
-
The drug is used for the treatment of bronchial asthma, exacerbations of chronic obstructive pulmonary disease (COPD), and very severe croup (subglottic laryngitis) in children that requires hospitalization.
Form: suspension, for inhalation
Active substance Dosage budesonide 0.25 mg/ml ATC: R03BA02
Manufacturer: Genetik S.p.A.
-
The drug is used for the treatment of bronchial asthma, exacerbations of chronic obstructive pulmonary disease (COPD), and very severe croup (subglottic laryngitis) in children that requires hospitalization.
Form: suspension, for inhalation
Active substance Dosage budesonide 0.5 mg/ml ATC: R03BA02
Manufacturer: Genetik S.p.A.
-
The drug is used for the treatment of bronchial asthma.
Form: inhalation, suspension under pressure
Active substance Dosage budesonide 50 mcg ATC: R03BA02
Manufacturer: Laboratorio Aldo-Union, S.L.
-
The drug is used for the treatment of bronchial asthma.
Form: inhalation, suspension under pressure
Active substance Dosage budesonide 200 mcg/dose ATC: R03BA02
Manufacturer: Laboratorio Aldo-Union, S.L.
-
The drug is intended for the treatment of bronchial asthma in adults and children. It is also recommended for infants and children for the treatment of croup (laryngotracheobronchitis) requiring hospitalization.
Form: suspension, for inhalation
Active substance Dosage budesonide 0.25 mg/ml ATC: R03BA02
Manufacturer: Genetik S.p.A.
-
The drug is indicated for the treatment of bronchial asthma in adults and children. It is also recommended for infants and children with croup (laryngotracheobronchitis) requiring hospitalization.
Form: suspension, for inhalation
Active substance Dosage budesonide 0.50 mg/ml ATC: R03BA02
Manufacturer: Genetik S.p.A.
-
The drug is used for the prophylactic treatment of bronchial asthma in adults and children, as well as for the treatment of children suffering from croup (laryngotracheobronchitis).
Form: suspension, for inhalation
Active substance Dosage budesonide 0.25 mg/ml ATC: R03BA02
-
The drug is intended for the treatment of bronchial asthma in adults and children, as well as for the treatment of children suffering from croup (laryngotracheobronchitis).
Form: suspension, for inhalation
Active substance Dosage budesonide 0.5 mg/ml ATC: R03BA02
-
The drug is used for the prophylactic treatment of bronchial asthma in adults and children. It is also recommended for infants and children with croup (laryngotracheobronchitis) requiring hospitalization.
Form: suspension, for inhalation
Active substance Dosage budesonide 0.5 mg/ml ATC: R03BA02
Manufacturer: Genetik S.p.A. (manufacturing and packaging, quality control)
-
The drug is intended for the regular treatment of bronchial asthma in adults and adolescents (from 12 years old), as well as for the symptomatic treatment of adults with chronic obstructive pulmonary disease (COPD).
Form: powder for inhalation
Active substance Dosage budesonide 160 mcg/dose formoterol 4.5 mcg/dose ATC: R03AK07
Manufacturer: Orion Corporation
-
The drug is intended for the regular treatment of bronchial asthma in adults, adolescents, and children aged 6 years and older. It is used for both maintenance therapy and symptom relief.
Form: powder for inhalation
Active substance Dosage budesonide 80 mcg/dose formoterol 4.5 mcg/dose ATC: R03AK07
Manufacturer: Orion Corporation (full-cycle manufacturing)
-
The drug is intended for the regular treatment of bronchial asthma in adults and adolescents (from 12 years old), as well as for the symptomatic treatment of chronic obstructive pulmonary disease (COPD) in adults from 18 years old.
Form: powder for inhalation
Active substance Dosage budesonide 320 mcg formoterol 9 mcg ATC: R03AK07
Manufacturer: Orion Corporation (full-cycle manufacturing)
-
The drug is used to achieve remission in adults with mild to moderate active ulcerative colitis (if treatment with 5-aminosalicylic acid is not effective), as well as to achieve remission in microscopic colitis.
Form: tablets, extended-release
Active substance Dosage budesonide 9 mg ATC: A07EA06
Manufacturer: COSMO S.p.A.
-
The drug is prescribed to adults and children from 12 years of age for the regular treatment of bronchial asthma, and to adults from 18 years of age for the symptomatic treatment of chronic obstructive pulmonary disease (COPD).
Form: powder, inhalation, metered
Active substance Dosage budesonide 160 mcg formoterol 4.5 mcg ATC: R03AK07
Manufacturer: Aeropharm GmbH (manufacturing in bulk, primary and secondary packaging, testing, batch release)
-
The drug is prescribed to adults and children from 12 years of age for the regular treatment of bronchial asthma, as well as to adults from 18 years of age for the symptomatic treatment of chronic obstructive pulmonary disease (COPD).
Form: powder, inhalation, metered
Active substance Dosage budesonide 320 mcg formoterol 9 mcg ATC: R03AK07
Manufacturer: Aeropharm GmbH (manufacturing in bulk, primary and secondary packaging, testing, batch release)
-
The drug is prescribed for adults and children from 12 years of age for the regular treatment of bronchial asthma, as well as for adults from 18 years of age for the symptomatic treatment of severe chronic obstructive pulmonary disease (COPD).
Form: aerosol, metered for inhalation
Active substance Dosage budesonide 200 mcg formoterol 6 mcg ATC: R03AK07
Manufacturer: Medispray Laboratories Pvt. Ltd.
-
The drug is used for the prophylactic treatment of bronchial asthma in adults and children, as well as for the treatment of croup in infants and children requiring hospitalization.
Form: suspension, for inhalation
Active substance Dosage budesonide 0.125 mg/ml ATC: R03BA02
Manufacturer: Farmak JSC
-
The drug is used for the prophylactic treatment of bronchial asthma in adults and children, as well as for the treatment of croup (laryngotracheobronchitis) in infants and children requiring hospitalization.
Form: suspension, for inhalation
Active substance Dosage budesonide 0.25 mg/ml ATC: R03BA02
Manufacturer: Farmak JSC
-
The drug is used for the prophylactic treatment of bronchial asthma in adults and children, as well as for the treatment of croup in infants and children requiring hospitalization.
Form: suspension, for inhalation
Active substance Dosage budesonide 0.5 mg/ml ATC: R03BA02
Manufacturer: Farmak JSC
-
The drug is used for the treatment of bronchial asthma, exacerbations of chronic obstructive pulmonary disease (COPD), and very severe croup (subglottic laryngitis) in children.
Form: suspension, for inhalation
Active substance Dosage budesonide 0.25 mg/ml ATC: R03BA02
Manufacturer: AstraZeneca AB (manufacturing, quality control and batch release; quality control)
-
The drug is used for the treatment of bronchial asthma, exacerbations of chronic obstructive pulmonary disease (COPD), and severe croup (subglottic laryngitis) in children.
Form: suspension, for inhalation
Active substance Dosage budesonide 0.5 mg/ml ATC: R03BA02
Manufacturer: AstraZeneca AB (manufacturing, quality control and batch release; quality control)
-
The drug is used for the treatment of persistent bronchial asthma, as well as for the treatment of moderate to severe chronic obstructive pulmonary disease (COPD).
Form: powder for inhalation
Active substance Dosage budesonide 100 mcg ATC: R03BA02
Manufacturer: AstraZeneca AB (manufacturing, filling, quality control, labeling, secondary packaging and batch release)
-
The drug is used for the treatment of persistent bronchial asthma, as well as for the treatment of moderate to severe chronic obstructive pulmonary disease (COPD).
Form: powder for inhalation
Active substance Dosage budesonide 200 mcg ATC: R03BA02
Manufacturer: AstraZeneca AB (manufacturing, filling, quality control, labeling, secondary packaging and batch release)
-
The drug is prescribed for the regular treatment of bronchial asthma. It is used either for continuous maintenance or for both prevention and rapid relief of symptoms.
Form: powder, inhalation, metered
Active substance Dosage budesonide 80 mcg formoterol 4.5 mcg ATC: R03AK07
Manufacturer: AstraZeneca AB (manufacturing, filling, quality control, labeling, secondary packaging and batch release)
-
The drug is prescribed to adults and children from 12 years of age for the regular treatment of bronchial asthma, as well as to adults from 18 years of age for the symptomatic treatment of chronic obstructive pulmonary disease (COPD).
Form: powder, inhalation, metered
Active substance Dosage budesonide 160 mcg formoterol 4.5 mcg ATC: R03AK07
Manufacturer: AstraZeneca AB (manufacturing, filling, quality control, labeling, secondary packaging and batch release)
-
The drug is prescribed for the regular treatment of bronchial asthma in adults and children aged 12 years and older, as well as for the symptomatic treatment of adults with chronic obstructive pulmonary disease (COPD).
Form: powder, inhalation, metered
Active substance Dosage budesonide 320 mcg formoterol 9.0 mcg ATC: R03AK07
Manufacturer: AstraZeneca AB (manufacturing, filling, quality control, labeling, secondary packaging and batch release)
-
The drug is intended for the maintenance therapy of adult patients with moderate to severe chronic obstructive pulmonary disease (COPD) if other combination therapies do not provide sufficient effect.
Form: inhalation, suspension under pressure
Active substance Dosage formoterol 5 mcg glycopyrronium 7.2 mcg budesonide 160 mcg ATC: R03AL11
Manufacturer: AstraZeneca Dunkerque Production (manufacturing, primary packaging, secondary packaging, quality control and batch release)